Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR_based lipoprotein profiling.
暂无分享,去创建一个
[1] V. Wong,et al. A new definition for metabolic associated fatty liver disease: an international expert consensus statement. , 2020, Journal of hepatology.
[2] Luca Valenti,et al. Update on NAFLD genetics: from new variants to the clinic. , 2020, Journal of hepatology.
[3] N. Lundbom,et al. Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids. , 2019, JCI insight.
[4] Jonathan C. Cohen,et al. PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice , 2019, Hepatology.
[5] H. Völzke,et al. The PNPLA3 SNP rs738409:G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort. , 2017, Journal of hepatology.
[6] Jonathan C. Cohen,et al. Adiposity Amplifies the Genetic Risk of Fatty Liver Disease Conferred by Multiple Loci , 2017, Nature Genetics.
[7] The prevalence of multiple non-communicable diseases among middle-aged and elderly people: the Shanghai Changfeng Study , 2017, European Journal of Epidemiology.
[8] Jonathan C. Cohen,et al. Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins* , 2016, The Journal of Biological Chemistry.
[9] Anne Tybjærg-Hansen,et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease , 2014, Nature Genetics.
[10] Michael Charlton,et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. , 2012, Gastroenterology.
[11] Meng-Su Zeng,et al. Standardized Ultrasound Hepatic/Renal Ratio and Hepatic Attenuation Rate to Quantify Liver Fat Content: An Improvement Method , 2011, Obesity.
[12] A. Hofman,et al. The Shanghai Changfeng Study: a community-based prospective cohort study of chronic diseases among middle-aged and elderly: objectives and design , 2010, European Journal of Epidemiology.
[13] Alexander Pertsemlidis,et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.